Skip to main content
✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026
Rates
NexGen Franchising, LLC NexGenEsis Healthcare

NexGen Franchising, LLC NexGenEsis Healthcare

The total investment to open a NexGen Franchising, LLC NexGenEsis Healthcare franchise ranges from $34,810 to $90,060. The initial franchise fee is $55,000. Ongoing royalties are 7% plus a 1% advertising fee.

What is the NexGen Franchising, LLC NexGenEsis Healthcare franchise?

NexGen Franchising, LLC NexGenEsis Healthcare addresses patients with chronic pain, degenerative joint conditions, and sports injuries who want alternatives to long term opioid prescriptions and invasive surgery. Founded by Dr. Greg Picou, Chairman of the Board, the company provides physician supervised, nonsurgical care combining regenerative medicine with primary care. Dr. Lawrence Bourgeois serves as Chief Executive Officer and Dr. Andrew McNall as Chief Operating Officer. The company has been associated with headquarters in multiple locations as it expands across Texas and Mississippi. Franchise development began around 2020 to 2022. By 2024, the system had 12 U.S. units, including 10 company owned locations and 2 franchised clinics, with additional units awarded and in development. Services include primary care, urgent care, telemedicine, platelet rich plasma injections, alpha 2 macroglobulin therapy, and bone marrow aspirate procedures. NexGenEsis is an early stage healthcare franchise with a clinically focused model. The analysis is based on public disclosures, franchise documents, and industry data sources and was produced independently by PeerSense, a commercial capital advisory firm that introduces franchise buyers to SBA and conventional lenders but does not lend or approve loans.

The alternative healthcare and regenerative medicine industry represented approximately $29 billion in annual U.S. market size in 2023. The global regenerative medicine market is projected to grow at a 16% compound annual growth rate, with some analyses estimating growth above 24% per year depending on the category definition. In the United States, regenerative medicine is projected to reach $5 billion by 2030 and has been described as a $10 billion opportunity over a longer period. Demand is supported by an aging population concerned with mobility, consumers seeking nonaddictive pain management after the opioid crisis, and interest in minimally invasive care. Some patients are willing to pay out of pocket for treatments intended to shorten recovery from months to weeks. The franchise channel has limited direct competition in regenerative medicine. NexGenEsis also offers treatments for weight loss, hair loss, and erectile dysfunction, extending its potential patient base into the broader wellness market.

The NexGen Franchising, LLC NexGenEsis Healthcare franchise fee is $55,000. Veterans receive a 10% discount on that fee. Estimated initial investment ranges from approximately $168,250 to $361,495, depending largely on geography, lease conditions, and required improvements. Costs include an Initial Neuropathy Package of $3,500; Modality Equipment Package costs of $6,500 to $10,000; Regenerative Equipment Package costs of $15,000 to $35,000; Furniture, Fixtures, and Supplies of $10,000 to $20,000; Computer and POS Systems of $2,500 to $10,000; three months of Lease Payments of $3,750 to $30,000; Leasehold Improvements of $10,000 to $75,000; Signage of $2,500 to $5,000; Insurance of $4,000 to $7,000; Professional Fees of $2,000 to $10,000; Training Costs of $1,500 to $10,000; Medical Training of up to $4,495; and three months of Additional Funds for working capital of $50,000 to $80,000. Licenses and permits cost $500 to $1,500, while utility and security deposits cost $1,500 to $5,000. Reported minimum liquid capital requirements range from $100,000 to $168,250. SBA loan eligibility is a financing option prospective franchisees should evaluate, and veterans should request written confirmation of the fee discount.

NexGenEsis clinics use physician supervised care, with treatment sessions lasting 30 to 90 minutes and same day discharge. Franchisees manage healthcare professionals who provide regenerative injections, primary care consultations, and telemedicine services. Buyers may open a new clinic through an investor model or medical professional model, convert an existing medical practice, or add regenerative treatments to an established healthcare operation. These paths can produce different build out costs and timelines, contributing to the $168,250 to $361,495 investment range. Training includes NexGenEsis University and hands on clinical instruction covering equipment, products, scheduling and billing, customer service, sales, and marketing for a cash pay model. Standard training costs $1,500 to $10,000, with medical training priced up to $4,495. Corporate support includes business planning, employee recruitment, and healthcare compliance and safety guidance. Each franchisee receives an exclusive territory covering 175,000 to 200,000 residents. NexGenEsis agrees not to establish competing franchise locations within that area, while retaining rights for corporate locations and multi area marketing programs outside it. A 12 month patient follow up program includes appointments at six months and twelve months.

If the $959,704 figure is accurate, it is more than 200% above that category figure, but buyers should verify it through franchisee calls. Regenerative therapies such as platelet rich plasma, alpha 2 macroglobulin, and bone marrow aspirate injections typically are not reimbursed by insurance, leaving the practice dependent on patient payments and effective local marketing. Strong marketing may support patient volume, while underinvested locations may have unused appointment capacity. Applying the 7% royalty to $959,704 produces an annual royalty obligation of approximately $67,179.

NexGen Franchising, LLC NexGenEsis Healthcare has grown since entering franchising between 2020 and 2022. The system has 12 total U.S. locations, while reports cite 24 franchise units awarded throughout its history and 17 awarded during the most recent 12 month period. This difference indicates that awards are occurring faster than locations are opening. The brand has focused on Texas and Arizona within the Sun Belt, with additional markets in Hawaii, Louisiana, Mississippi, and Pennsylvania. Its stated mission is to bring world class medical care to every corner of the country. Telemedicine allows clinics to reach patients across wider areas and maintain contact between in person treatments. With the broader industry growing at 16% to 24% annually, additional franchise competitors may enter the category, making existing territories, recognition, and clinical reputation relevant considerations.

The intended NexGen Franchising, LLC NexGenEsis Healthcare franchisee can manage healthcare professionals, operate in a cash pay setting, support local marketing, and hire qualified medical staff. The company offers an investor model and a medical professional model. Existing primary care practices, physical therapy practices, and urgent care operators may also consider the conversion or service extension paths. Territory opportunities include Texas, Arizona, Hawaii, Louisiana, Mississippi, and Pennsylvania. The company operates exclusively in the United States and has no announced international expansion plans. NexGenEsis has stated that the next 10 new franchisees will have direct contact with Dr. Lawrence Bourgeois. Buyers should review franchise agreement terms, renewal rights, and transfer conditions with a qualified franchise attorney.

The investment range is $168,250 to $361,495, and the $55,000 franchise fee includes a 10% veteran discount. Key issues for independent review include the small number of open franchised locations, the need to attract cash paying patients, and brand recognition compared with established healthcare franchise systems. The $55,000 fee and 7% royalty should be assessed against revenue information verified through direct franchisee interviews. PeerSense provides independent franchise intelligence, including SBA lending history, Loan Activity Score, location maps with Google ratings, FDD financial data, and comparison tools for evaluating NexGenEsis against healthcare and regenerative medicine franchise opportunities.

According to its Franchise Disclosure Document or public business records, NexGen Franchising, LLC NexGenEsis Healthcare has 198 locations, all owned by franchisees. Cost figures are based on the 2025 Franchise Disclosure Document. To correct a figure, email the current FDD and the differing item numbers to info@peersense.com, and this page will be updated.

2025 FDD ON FILE

Franchising since 2006 · 198 locations

Investment

$34,810 to $90,060

Franchise Fee

$55,000

Total Units

198

198 franchised

SBA Lending Activity for NexGen Franchising, LLC NexGenEsis Healthcare

Loan Activity Score

This franchise has not yet been scored by the Franchise Performance Index. Scores are calculated based on public FDD data, SBA loan performance, and system level metrics.

Key Highlights

Item 19 financial data disclosed
198 locations nationwide

Data Insights

Key performance metrics for NexGen Franchising, LLC NexGenEsis Healthcare based on SBA lending data

Investment Tier

Low cost entry

$34,810 to $90,060 total

Why NexGen Franchising, LLC NexGenEsis Healthcare Doesn't Appear in Public SBA Data

The SBA 7(a) program publishes loan level data for every approved franchise borrower. NexGen Franchising, LLC NexGenEsis Healthcare does not currently appear in those public records, and that absence carries useful information for prospective franchisees evaluating this brand.

Likely explanations for the absence

  • Low capital requirements (under $50K total) often fall below the typical SBA loan threshold, so operators self fund or use personal credit instead.

Absence from SBA records does not mean a brand is un fundable. It typically means the franchise system uses alternative capital sources, or that current franchisees self fund, secure conventional bank financing, or roll over equity from a prior business sale rather than going through an SBA guaranteed 7(a) loan. For prospective NexGen Franchising, LLC NexGenEsis Healthcare franchisees, the practical question is which financing path actually closes for this brand's profile.

Data window: SBA 7(a) approvals reported through the most recent FOIA release. Absence of NexGen Franchising, LLC NexGenEsis Healthcare from this window does not reflect lender denial. It reflects no 7(a)-program activity recorded for this brand in the public dataset.

Payment Estimator

Loan Amount$28K
Interest Rate9.5%
Term (Years)10 yr

Estimated Monthly Payment

$360

Principal & Interest only

Indicative only, as of November 1, 2026. Not a quote, commitment or offer of credit. Final pricing, leverage and terms are determined by the lender at underwriting, after full transaction materials are reviewed. PeerSense sources the file. The lender sets pricing. What these terms mean.

Locations

NexGen Franchising, LLC NexGenEsis Healthcare, unit breakdown

Total Units
N/A
Franchisee Owned
n/a
System Owned
n/a
Closed
n/a

Explore Funding for NexGen Franchising, LLC NexGenEsis Healthcare

Our business financing consultants help connect you with the right lending partners. Referral fee paid at closing.

Optional: checking the consent box lets us call or text you about your funding. You can still submit without it.

Referral fee at closing

Or get an instant analysis

Scan Your Deal Instantly

3 FDDs Available for NexGen Franchising, LLC NexGenEsis Healthcare

Review franchise fees, investment ranges, royalties, Item 19 financial data, and year over year trends. Request complimentary access through your PeerSense funding advisor.

NexGen Franchising, LLC NexGenEsis Healthcare

Page Review

Reviewed by Edward L. Freeman, Founder and Managing Director, PeerSense

  • PeerSense is a capital advisory firm that places commercial financing with direct capital sources; the capital source sets final terms.
  • Edward L. Freeman founded PeerSense in January 2020.
  • He is a Registered Franchise Consultant with Business Alliance, Inc., a credential issued in March 2022, and worked as a franchise consultant there from March 2022 to May 2023.
  • His recorded experience includes a $22 million SBA construction loan, with about $16 million funded on the deal.
  • In the 12 months through September 30, 2026, PeerSense tracked 912 publicly announced financings with a disclosed size of $361.32 billion. PeerSense Capital Data Report · Methodology page

Last reviewed LinkedIn profileAbout Edward Freeman

This is not a franchise offering and does not constitute financial, investment, or legal advice. Data is sourced from Franchise Disclosure Documents (FDDs), public filings, and third party sources and may contain inaccuracies. The figures reflect the FDD on file for the year shown and may have been superseded or extracted with errors. PeerSense is not a financial advisor, attorney, or accountant. Always consult the brand's current FDD and seek professional guidance from a qualified attorney, accountant, or financial advisor before making any franchise investment decision. See full Terms & Conditions.